
CRA International (CRAI) | News Based Sentiment Analysis
TL;DR: CRA International News Sentiment Overview
Last Updated: Oct 03, 2025 (UTC)News based Sentiment: MIXED | Importance Score: 6
Key Insights
Latest News Analysis: CRA International
Last Updated: Oct 03, 2025 (UTC)CRAI: Upgraded Outlook & Renewable Energy Focus
Detailed Analysis
- On October 1, 2025, CRA International (CRAI) received an upgrade to a Zacks Rank #2 (Buy), signaling positive momentum. Analysts have been consistently revising earnings estimates upwards, with the fiscal year 2025 EPS estimate holding steady at $8.04 per share – the same as the previous year, suggesting stable profitability. This upgrade places CRAI among the top 20% of stocks covered by Zacks based on these revisions, indicating strong investor confidence.
- Just two days later, on October 3, 2025, CRA International raised its revenue guidance for fiscal year 2025 to a range of US$730 million to US$745 million. This optimistic outlook is driven by strong visibility into near-term demand and a favorable environment of heightened global deal activity, suggesting the company anticipates continued growth.
- CRA International will manage a Request for Proposal (RFP) process for FirstEnergy Corp.'s Ohio subsidiaries to secure Renewable Energy Credits (RECs), as announced on October 1, 2025. Bid proposals are due by November 4, 2025, and the RFP aims to procure both solar and non-solar RECs to meet the companies’ 2025 renewable energy obligations, showcasing CRAI’s role in the expanding renewable energy sector.
- However, coinciding with the FirstEnergy REC RFP webinar on October 1, 2025, CRA International experienced a 2.44% stock price decline. While the reasons for this decline weren’t detailed, it suggests the market reacted cautiously to the news, potentially due to uncertainty surrounding the RFP process or broader market conditions.
- Investors should note that CRA International is scheduled to announce its third-quarter 2025 earnings report before market opens on October 30, 2025. The consensus EPS for Q3 2025 is projected at $1.80, with expected revenue of $179.42 million, providing a key date for evaluating the company’s recent performance.
The Investment Story: October saw CRA International benefit from an analyst upgrade and increased revenue guidance, demonstrating positive momentum, but a stock price dip following an RFP announcement introduced a note of caution. The company is actively involved in the renewable energy sector, positioning it for growth in a key market.
What It Means for Investors: The positive analyst rating and revenue guidance suggest potential for continued stock appreciation, but the stock price decline highlights the importance of monitoring the RFP process and broader market conditions. Investors should pay close attention to the Q3 earnings report on October 30, 2025, to assess the company’s performance against expectations.
Looking Ahead: The November 4, 2025, bid proposal deadline for the FirstEnergy REC RFP will be a key event to watch, as will the Q3 earnings report on October 30, 2025. Investors should also monitor any further analyst commentary and market reactions to these developments.
The Bottom Line: CRA International appears to be navigating a favorable environment with strong demand and positive analyst sentiment, but the recent stock price dip serves as a reminder of potential market volatility. The upcoming earnings report and RFP outcome will be crucial in determining the company’s trajectory.
CRA International Competitors News Sentiment Analysis
Compare news sentiment across the main stock and its key competitors based on recent market analysis.
Company | Sentiment | Recent Headline | Importance |
---|---|---|---|
![]()
CRA International Main
crai | nasdaq | mixed | CRAI: Upgraded Outlook & Renewable Energy Focus |
6
/10 |
![]()
VRSK | NASDAQ | mixed | Verisk: Strong Earnings, AI Push, and Mixed Signals |
7
/10 |
![]()
EFX | NYSE | negative | Equifax Faces FICO Headwind Amidst Expansion |
8
/10 |
![]()
ICFI | NASDAQ | mixed | ICF International: Positive Momentum Amidst Federal Headwinds |
7
/10 |
![]()
SBC | NASDAQ | positive | SBC Medical: Trading Suspension Lifted, Stock Rises |
6
/10 |
![]()
BAH | NYSE | mixed | Booz Allen: Q3 Beat, $1.58B Contract, and Analyst Optimism |
7
/10 |
Note: Sentiment analysis is based on the most recent monthly news data. Importance scores range from 1-10, with higher scores indicating greater market relevance.
Important: News sentiment data is updated regularly and based on publicly available news sources. Sentiment scores and analysis represent algorithmic assessments of market sentiment. This information is for educational purposes only and should not be considered as investment advice. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.